Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer’s as a potential first indication. Longevity biotech…
Muna Therapeutics targets brain resilience with drug designed to enhance neural health by harnessing established protective mechanisms. Denmark’s Muna Therapeutics…
